Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
TSE:4502
Price:
4 125 JPY
-0.43%
Market Closed
Updated:
May 6, 2024
Takeda Pharmaceutical Co Ltd
Other Operating Expenses
|
Takeda Pharmaceutical Co Ltd
Other Operating Expenses Peer Comparison
Comparables:
4568
4578
4523
4519
4503
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Other Operating Expenses
-¥110.9B
|
CAGR 3-Years
39%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
6%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Other Operating Expenses
¥37.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Other Operating Expenses
¥2.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Eisai Co Ltd
TSE:4523
|
Other Operating Expenses
¥4.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
-5%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Other Operating Expenses
¥28.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
678%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Other Operating Expenses
-¥82.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
11%
|
See Also
What is Takeda Pharmaceutical Co Ltd's Other Operating Expenses?
Other Operating Expenses
-110.9B
JPY
-110.9B
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Other Operating Expenses amounts to -110.9B JPY.
What is Takeda Pharmaceutical Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 10Y
6%
6%
Over the last year, the Other Operating Expenses growth was 2%. The average annual Other Operating Expenses growth rates for Takeda Pharmaceutical Co Ltd have been 39% over the past three years , -20% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
